Ethical, Legal and Social Implications (ELSI) Exploratory/Developmental Research Grant (R21 Clinical Trial Optional)
Funding available for research on ethical, legal, and social impacts of human genetics and genomics, with focus on new technologies and stakeholder involvement.
Funder: National Institutes of Health
Due Dates: June 17, 2025 (New) | July 18, 2025 (Renewal/Resubmission/Revision) | October 20, 2025 (New) | November 18, 2025 (Renewal/Resubmission/Revision) | February 19, 2026 (New) | March 18, 2026 (Renewal/Resubmission/Revision) | June 18, 2026 (New) | July 20, 2026 (Renewal/Resubmission/Revision) | October 20, 2026 (New) | November 18, 2026 (Renewal/Resubmission/Revision)
Funding Amounts: Up to $275,000 direct costs over 2–3 years; no more than $200,000 in any single year; max project period 3 years.
Summary: Supports exploratory or developmental research on the ethical, legal, and social implications (ELSI) of human genetics and genomics, with emphasis on new technologies and stakeholder engagement.
Key Information: Clinical trials are optional; foreign and domestic applicants eligible; strong data sharing and resource sharing plans required.
Description
This funding opportunity supports exploratory and developmental research projects that investigate the ethical, legal, and social implications (ELSI) of human genetics and genomics. The program encourages studies that break new ground, extend previous discoveries, or develop preliminary data for larger projects. Research may use single or mixed methods, including empirical qualitative and quantitative approaches, as well as conceptual, legal, and normative analyses. Direct engagement with communities and stakeholders is encouraged but not required.
Of particular interest are projects examining the implications of new or emerging genomic technologies, novel uses of genomic information, and the impact of genomics on individuals, families, communities, and society. Multidisciplinary teams and diverse perspectives are encouraged.
